1. Lindvall C, Nordenskj?ld M, Porwit A, Bj?rkholm M, Blennow E. Molecular cytogenetic characterization of acute myeloid leukemia and myelodysplastic syndromes with multiple chromosome rearrangements. Haematologica 2001; 86(11): 1158-1164.
2. Mauritzson N, Johansson B, Albin M, Billstr?m L, Ahlgren T, Mikoczy Z, Nilsson PG, Hagmar L, Mitelman F. A single-center population-based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: karyotypic features in relation to morphology, age and gender. Eur J Haematol 1999; 62(2): 95-102.
3. Tanaka K, Arif M, Eguchi M, Shintani T, Kuma?ravel TS, Asaoku H, Kyo T, Dohy H, Kamada N. Inter?phase fluorescence in situ hybridization overcomes pitfalls of G-banding analysis with special reference to underestimation of chromosomal aberration rates. Cancer Genet Cytogenet 1999; 115(1): 32-38.
4. Verma RS, Babu A. Tissue culture techniques and chromosome preparation. In: Verma RS, Babu A, eds. Human Chromosomes Principles and Techniques, 2nd ed. New York: Mc Graw-Hill Inc, 1995; 6-71.
5. Mitelman F. ISCN: an international system for human cytogenetic nomenclature. Basel: S. Karger; 1995.
6. Staudt LM. Molecular diagnosis of the hematologic cancers. N Engl J Med 2003; 348(18): 1777-1785.
7. Ma SK, Wan TSK, Chan LC. Cytogenetics and molecular genetics of childhood leukemia. Hematol Oncol 1999; 17(3): 91-105.
8. Grimwade D, Biondi A, Mozziconacci M-J, Hage?meijer J. Berger R, Neat M, Howe K, Dastugue N, Jansen J, Radford-Weiss I, Lo Coco F, Lessard M, Hernandez JM, Delabesse E, Head D, Liso V, Sainty D, Flandrin G, Solomon E, Birg F, Lafage Pochitaloff M. Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Blood 2000; 96(4): 1297-1308.
9. Hoelzer D, G?kbuget N, Ottmann O, Pui C-H, Relling MV, Appelbaum FR, Van Dongen JJM, Szcze?panski T. Acute lymphoblastic leukemia. Hematology 2002; 162-192.
10. Nashed AL, Rao KW, Gulley ML. Clinical applications of BCR-ABL molecular testing in acute leukemia. J Molec Diagn 2003; 5(2): 63-72.
11. Uckun FM, Nachman JB, Sather HN, Sensel MG, Kraft P, Steinherz PG, Lange B, Hutchinson R, Reaman GH, Gaynon PS, Heerema NA. Clinical significance of Philadelphia chromosome-positive pediatric acute lym?phoblastic leukemia in context of contemporary intensive therapies: a report from the children’s cancer group. Cancer 1998; 83(9): 2030-2039.
12. Cox CM, Panetta P, Lo-Coco F, Del Poeta G, Venditti AV, Maurillo L, Del Principe MI, Mauriello A, Anemona L, Bruno A, Mazzone C, Palombo P, Amadori S. Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation. Am J Clin Pathol 2004; 122(2): 298-306.
13. Bagg A. Clinical applications of molecular genetic testing in hematologic malignancies: advantages and limitations. Hum Pathol 2003; 34(4): 352-358.
14. Braziel RM, Shipp MA, Feldman AL, Espina V, Winters M, Jaffe ES, Petricoin III Efi Liotta LA. Molecular diagnostics. Hematology 2003; 279-293.
